MedPath

Incidence of symptomatic meibomian gland dysfunction and characteristics of meibomian gland after cataract surgery

Recruiting
Conditions
Symptomatic meibomian gland dysfunction after cataract surgery
Cataract surgery, meibomian gland dysfunction, phacoemulsification
Registration Number
TCTR20240527005
Lead Sponsor
Chulalongkorn university
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
77
Inclusion Criteria

1.Able to read, understand and sign an informed consent form
2.Able and willing to comply with the follow-up schedule and requirements
3.Patients diagnosed with cataracts with an indication for cataract surgery

Exclusion Criteria

1.Preexisting symptomatic meibomian gland dysfunction
2.Complicated cataract surgery
3.Other ocular surface diseases
4.Patients who had used artificial tears within the past 1 week or topical medication to treat another ocular disease or systemic drugs that were known to affect the tear film and ocular surface
5.History of lid spa in the past 1 week
6.History of ocular trauma, ocular surgery, and ocular infection in the past 3 months, except for those causing permanent damage to the ocular surface
7.Contact lens wearer
8.Pregnancy and lactation

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Incidence of symptomatic MGD at 1 months after cataract surgery Incidence
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath